Thirteen years after the GSK China scandal exploded onto the global stage, its lessons remain as urgent as ever for compliance professionals and business leaders. In this podcast series, we revisit the case not simply as corporate history, but as a living cautionary tale about culture, incentives, third parties, investigations, and governance. Each episode explores what went wrong, why it went wrong, and how those failures still echo in today’s compliance and ethics landscape. Join me as we unpack the scandal and draw practical lessons for building stronger, more resilient organizations. In this inaugural episode, we take a deep dive into the 2013 GSK China bribery scandal and examine why it still stands as one of the most important case studies in corporate compliance, governance, and culture. Our hosts are Timothy and Fiona.
The episode examines how multinational companies should manage third-party relationships and compliance in opaque markets like China when traditional intelligence-gathering is curtailed by privacy laws, using the case of corporate investigators Peter Humphreys and his wife Ying Zeng, who were hired by GSK to investigate a sex-tape scandal but were convicted and imprisoned for purchasing Chinese citizens’ personal data. The discussion highlights how the verdict created operational uncertainty for due diligence, M&A, supplier vetting, and anti-bribery efforts, and notes Humphrey’s claim that GSK withheld that it faced internal whistleblower corruption allegations. Drawing on DOJ expectations and an SCCE framework, it argues for shifting from “vet and forget” to continuous third-party management across five steps, reinforcing business justification, questionnaires, contracts, and ongoing oversight with mitigations like capped commissions, detailed invoice review, early audits, and use of public records and in-person interviews.
Key Highlights
- Why Verification Matters
- Privacy Laws Change Everything
- When Partners Refuse Disclosure
- Build Your Own Intelligence
- Contract Controls and Oversight
Resources
GSK in China: A Game Changer for Compliance on Amazon.com
GSK in China: Anti-Bribery Enforcement Goes Global on Amazon.com
Tom Fox
Ed. Note-the voices of the hosts, Timothy and Fiona were created by Notebook LM based upon text written by Tom Fox
